Edition:
United Kingdom

Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

14.80USD
7:32pm BST
Change (% chg)

$-0.31 (-2.05%)
Prev Close
$15.11
Open
$15.16
Day's High
$15.19
Day's Low
$14.55
Volume
122,901
Avg. Vol
220,444
52-wk High
$43.85
52-wk Low
$14.31

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -1.436
FY 2018 Dec '18 0.00 -1.747
Sep '18 0.00 -1.285
Jun '18 0.00 -1.147
Mar '18 0.00 -1.047
FY 2017 Dec '17 0.00 -1.152
Sep '17 0.00 -1.020
Jun '17 0.00 -0.938
Mar '17 0.00 -0.883
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 8 0.00 0.00 0.00 0.00
Quarter Ending Dec-19 8 0.00 0.00 0.00 2.98
Year Ending Dec-19 8 0.00 0.00 0.00 0.83
Year Ending Dec-20 8 0.50 4.00 0.00 36.24
Earnings (per share)
Quarter Ending Sep-19 9 -1.40 -1.23 -1.71 -1.14
Quarter Ending Dec-19 9 -1.41 -1.26 -1.67 -1.14
Year Ending Dec-19 9 -5.69 -5.21 -6.60 -4.23
Year Ending Dec-20 9 -5.24 -4.00 -6.75 -3.57
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 98.06 34.39
P/E High - Last 5 Yrs. -- 170.35 54.26
P/E Low - Last 5 Yrs. -- 53.47 28.32
Beta 2.09 1.28 0.99
Price to Sales (TTM) -- 42.56 8.16
Price to Book (MRQ) 2.46 12.25 4.43
Price to Tangible Book (MRQ) 2.83 17.10 5.15
Price to Cash Flow (TTM) -- 65.05 24.27
% Owned Institutions -- 3.28 1.75

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.64
Dividend Yield - 5 Year Avg -- 0.05 1.37
Dividend 5 Year Growth Rate -- 0.86 6.82
Payout Ratio(TTM) -- 2.50 47.54

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 54.86 14.08
Sales (TTM) vs TTM 1 Yr. Ago -- 48.20 8.15
Sales - 5 Yr. Growth Rate -- 33.34 9.49
EPS (MRQ) vs Qtr. 1 Yr. Ago -37.25 -7.18 17.61
EPS (TTM) vs TTM 1 Yr. Ago -35.10 -- --
EPS - 5 Yr. Growth Rate -- 21.86 7.04
Capital Spending - 5 Yr. Growth Rate 554.12 25.24 7.83

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.83 2.54
Current Ratio (MRQ) 9.96 3.69 3.53
LT Debt to Equity (MRQ) 0.00 7.98 12.56
Total Debt to Equity (MRQ) 0.00 21.23 17.60
Interest Coverage (TTM) -- 31.27 14.78

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 23.45 50.18
Gross Margin - 5 Yr. Avg. -- 59.88 51.29
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -12.34 16.42
Operating Margin (TTM) -- -125.83 -7.11
Operating Margin - 5 Yr. Avg. -- -28.61 11.91
Pre-Tax Margin (TTM) -- -127.97 -7.48
Pre-Tax Margin - 5 Yr. Avg. -- -33.76 15.94
Net Profit Margin (TTM) -- -133.72 -11.27
Net Profit Margin - 5 Yr. Avg. -- -38.67 11.30
Effective Tax Rate (TTM) -- 17.35 20.61
Effective Tax Rate - 5 Yr. Avg. -- 19.08 24.48

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 10,290,012 881,672,098
Net Income/Employee (TTM) -821,585 2,290,007 103,217,315
Receivable Turnover (TTM) -- 12.47 5.91
Inventory Turnover (TTM) -- 2.43 3.66
Asset Turnover (TTM) 0.00 0.33 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -64.05 6.25 10.24
Return on Assets - 5 Yr. Avg. -45.34 5.94 11.20
Return on Investment (TTM) -67.99 7.59 12.67
Return on Investment - 5 Yr. Avg. -48.35 7.78 14.19
Return on Equity (TTM) -70.67 8.10 17.18
Return on Equity - 5 Yr. Avg. -50.75 8.73 15.56
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -31.60 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Atara Biotherapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -26.04 -27.02 27 3
13 Week -52.32 -53.55 31 4
26 Week -59.44 -63.71 33 29
52 Week -61.45 -63.82 76 5
YTD -56.51 -63.47 33 7
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 185
Total Shares Held: 51,567,234
3 Mo. Net Change: 228,324
# New Positions: 2
# Closed Positions: 2
# Increased Positions: 10
# Reduced Positions: 5
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.